Department of Pharmacognosy, University of Szeged, Szeged, Hungary.
PLoS One. 2013 Sep 3;8(9):e74181. doi: 10.1371/journal.pone.0074181. eCollection 2013.
Classical homeopathy is based on the therapeutic application of highly diluted homeopathic stocks. The indications of such medicines are determined by proving, i.e. by applying the remedies in healthy subjects. However, there are several complex homeopathic medicinal products on the market with approved therapeutic indications. The efficacy of these medicines has been assessed in clinical trials on patients. There is no upper limit of dosing for such homeopathic remedies, and these products often contain undiluted mother tincture. The aim of our study was to compare an allopathic herbal medicine and a homeopathic product containing undiluted mother tincture based on the same plant. Two products (an allopathic herbal medicine and a homeopathic product) containing Vitex agnus-castus extract were analyzed by HPLC-DAD for their agnuside and casticin contents. The agnuside content of the allopathic product was approximately four times higher, while the amount of casticin was in the same order of magnitude. Our experiments revealed the presence of active ingredients in allopathic quantity in a homeopathic preparation, highlighting the controversy between the principles of classical and practice of contemporary homeopathy. According to the principles of classical homeopathy these remedies cannot be considered as homeopathic remedies but rather as (allopathic) herbal ones. This phenomenon necessitates a case-by-case approach towards the possible adverse effects and drug interactions of homeopathics in the daily medical practice. Homeopathic products containing active agents in allopathic doses should be treated the same way as allopathic medicines from the point of view of quality assurance and pharmacovigilance.
顺势疗法以应用高度稀释的顺势疗法药物为基础。这些药物的适应症是通过验证确定的,即通过在健康受试者中应用这些药物来确定。然而,市场上有几种具有批准的治疗适应症的复杂顺势疗法药物。这些药物在对患者进行的临床试验中评估了其疗效。对于这些顺势疗法药物,没有最高剂量限制,并且这些产品通常含有未稀释的母酊剂。我们的研究目的是比较基于同一植物的顺势疗法产品和含有未稀释母酊剂的顺势疗法产品。通过 HPLC-DAD 分析两种含有马鞭草提取物的产品(顺势疗法产品和顺势疗法产品)的 agnuside 和 casticin 含量。顺势疗法产品中的 agnuside 含量约为顺势疗法产品的四倍,而 casticin 的含量则处于同一数量级。我们的实验揭示了顺势疗法制剂中存在顺势疗法剂量的活性成分,这突显了经典顺势疗法原则与当代顺势疗法实践之间的争议。根据经典顺势疗法的原则,这些药物不能被视为顺势疗法药物,而应被视为(顺势疗法)草药药物。这种现象需要在日常医疗实践中对顺势疗法药物的可能不良反应和药物相互作用进行个案分析。从质量保证和药物警戒的角度来看,应将含有顺势疗法剂量的活性成分的顺势疗法产品视为与顺势疗法药物相同的药物。